Literature DB >> 2429105

Ventricular hypertrophy--physiological mechanisms.

E M Vaughan Williams.   

Abstract

Adult cardiac myocytes are incapable of mitosis. Dead cells are replaced by connective tissue so that after myocardial infarction (MI), function can only be restored by compensatory hypertrophy of the surviving myocardium. In physiological hypertrophy in response to exercise, high altitude, or mild hypertension, additional myoplasm expands cell diameter in an orderly fashion; Z-lines are in register and the normal ratio of volume densities of contractile elements, mitochondria, and capillaries is conserved. In hypertrophy induced by aortic or pulmonary artery banding or by experimental or congenital hypertension, the borderline between physiological and pathological hypertrophy may be crossed, causing disorganization of fibers and an unfavourable contractile element to capillary ratio. There was, therefore, a need for a graded model of hypertrophy, which involves simulating an altitude of 6,000 m at sea level by supplying rabbits with appropriate nitrogen/oxygen mixtures. In this environment, 50% right ventricular hypertrophy can be achieved without alteration of left ventricular weight or hematocrit. Longer exposures produced 100% right ventricular hypertrophy, with only moderate increases in hematocrit and left ventricular weight. It is well known that adrenergic stimulation causes cardiac hypertrophy, and it has been suggested that release of a trophic factor from sympathetic nerves, either noradrenaline or a protein, might be a necessary stimulus for growth. If so, long-term treatment of post-MI patients with beta-adrenergic blocking agents could inhibit a desirable compensatory hypertrophy of the surviving myocardium. In the above model it has been found, however, that neither beta-blockade nor chemical sympathectomy with guanethidine or 6-hydroxydopamine had any effect on the hypertrophy, nor did treatment with verapamil or nifedipine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429105     DOI: 10.1097/00005344-198608003-00004

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy.

Authors:  D J Hildick-Smith; L M Shapiro
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Decreased susceptibility to arrhythmias in hypertrophied hearts of physically trained rats.

Authors:  P Bélichard; D Pruneau; J L Salzmann; R Rouet
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

3.  Mild hypoxia-induced cardiomyocyte hypertrophy via up-regulation of HIF-1α-mediated TRPC signalling.

Authors:  Wenfeng Chu; Lin Wan; Dan Zhao; Xuefeng Qu; Fulai Cai; Rong Huo; Ning Wang; Jiuxin Zhu; Chun Zhang; Fangfang Zheng; Ruijun Cai; Deli Dong; Yanjie Lu; Baofeng Yang
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.